Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CYCLIC COMPOUND
Document Type and Number:
WIPO Patent Application WO/2018/047888
Kind Code:
A1
Abstract:
The present invention provides a compound that has an exceptional TLR4 signal-inhibiting action and can be useful as a drug for the prevention or treatment of autoimmune diseases and/or inflammatory diseases or diseases such as chemotherapy-induced peripheral neuropathy (CIPN), chemotherapy-induced neuropathic pain (CINP), liver disorders, ischemic reperfusion injury (IRI), etc. The present invention pertains to ethyl 6-((2-chloro-4-fluorobenzyl)sulfonyl)-3-hydroxycyclohex-1-ene-1-carboxylate or optical isomers thereof.

Inventors:
KOBAYASHI TOSHITAKE (JP)
SAITOH MORIHISA (JP)
WADA YASUFUMI (JP)
NEGORO NOBUYUKI (JP)
YAMASAKI MASASHI (JP)
TANAKA TAKAHIRO (JP)
KITAMOTO NAOMI (JP)
Application Number:
PCT/JP2017/032192
Publication Date:
March 15, 2018
Filing Date:
September 07, 2017
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TAKEDA PHARMACEUTICALS CO (JP)
International Classes:
C07C317/46; A61K31/235; A61P1/16; A61P9/10; A61P25/02; A61P29/00; A61P37/02; A61P43/00
Domestic Patent References:
WO2007132825A12007-11-22
WO2007123186A12007-11-01
WO2003084527A12003-10-16
WO2001010826A12001-02-15
Foreign References:
JP2013518032A2013-05-20
Other References:
YAMADA, MASAMI ET AL.: "Novel cyclohexene derivatives as anti-sepsis agents: Synthetic studies and inhibition of NO and cytokine production", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 16, no. 7, 2008, pages 3941 - 3958, XP022593503, DOI: doi:10.1016/j.bmc.2008.01.030
See also references of EP 3511320A4
Attorney, Agent or Firm:
TAKASHIMA, Hajime et al. (JP)
Download PDF: